HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.

Abstract
Forty-six elderly patients (mean age 60 years) suffering from diabetes mellitus (DM), or essential or arteriosclerotic hypertension (HT) were divided into 4 groups. Group 1 served as a control, group 2 was administered 1500 mg niceritrol, group 3 was administered 162 mg acetylsalicylic acid (ASA), and group 4 was administered both 1500 mg niceritrol and 162 mg ASA/day for 8 weeks. Niceritrol lowered serum levels of beta-lipoprotein and total cholesterol and increased HDL cholesterol, usually in 8 weeks. ASA did not affect the lipid-lowering effects of niceritrol. Platelet aggregation induced by epinephrine (1 microgram/ml), collagen (1 microgram/ml), and ADP (2 microM) was depressed in groups 2, 3 and 4. Degrees of depression were higher in groups administered ASA (groups 3 and 4) than in the group administered niceritrol alone (group 2). Plasma fibrinogen levels were lowered in groups administered niceritrol (groups 2 and 4) in 8 weeks. Apparent whole blood viscosity measured at shear rates of 37.6/s and 376/s was improved only in group 4 in 8 weeks, while hematocrit did not change during the study. Because flushing, the most frequent side effect of niceritrol, can be easily controlled by a low dose of ASA, and because the combination of the 2 drugs has some beneficial effects on blood rheology, this combination is considered worthwhile for treatment and prevention of atherosclerosis.
AuthorsT Hamazaki, K Hasunuma, S Kobayashi, H Shishido, S Yano
JournalAtherosclerosis (Atherosclerosis) Vol. 55 Issue 1 Pg. 107-13 (Apr 1985) ISSN: 0021-9150 [Print] Ireland
PMID4004983 (Publication Type: Journal Article)
Chemical References
  • Lipids
  • Nicotinic Acids
  • Fibrinogen
  • Niceritrol
  • Aspirin
Topics
  • Adult
  • Aged
  • Arteriosclerosis (complications, drug therapy)
  • Aspirin (therapeutic use)
  • Blood Viscosity (drug effects)
  • Diabetes Mellitus (drug therapy)
  • Female
  • Fibrinogen (analysis)
  • Humans
  • Hypertension (complications, drug therapy)
  • Lipids (blood)
  • Male
  • Middle Aged
  • Niceritrol (therapeutic use)
  • Nicotinic Acids (therapeutic use)
  • Platelet Aggregation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: